26- Alexander HR, Kelsen DG, Tepper JC 1997, Cancer of the
stomach p.1021-1049. In Devita V.T., Hellman S., Rosenberg
S.A. (ed), Cancer Principles and Practice of oncology.
Lippincott-Raven Publishers, Washington.
27- Blaser MJ. Helicobactr pylori and the pathogenesis of
gastroduodenal inflammation. J. İnfect. Dis. 1990; 161:626-
633.
28- Marshall BJ, and Warren JR. Unidentified curved bacilli in the
stomach of patients with gastritis and peptic ulceration. Lancet
1984; p:1311-1315.
29- NIH Consensus Conference. Helicobacter pylori in peptic
ulcer disease. NIH Consensus Development Panel on
Helicobacter pylori in peptic ulcer disease. 1994; Vol:12 No:1
Feb 7-9.
30- Crabtree JE, Wyatt JI, Sobolo GM, Miller G. Systemic and
mucosal humoral responses to Helicobacter pylori in gastrik
cancer. Gut 1993; 34:1339-1343.
31- Sipponen T, Kosunen TV, Valle J, Riihela MM, Seppala K.
Helicobacter pylori infection and chronic gastritis in gastric
cancer. J. Clin. Pathol. 1991; 45:319-323.
32- Talley NJ, Zinsmeister AR, Weaver A, Di Mongo EP. Gastric
adnocarcinoma and Helicobacter pylori infection. J. Natl.
Cancer. Inst. 1991; 83:1734-1739.
33- Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J,
Chang Y. Helicobacter pylori infection in intestinal-and
diffuse-type gastric adenocarcinomas. J Natl cancer Inst 1991;
May 1;83(9):640-643.
34- Nomura A, Stemmerman GN, Chyou P, Kato I. Helicobacter
pylori infection and gastric carcinoma among Japonase
Americans in Hawaii II. New Eng. Jour. Med. 1991;
325:1132-1136.
35- Forman D, Newell DG, Fullerten F, Yarnell JWG. Association
between infection with Helicobacter pylori and risk of gastric
cancer: Evidence from a prospective investigation. Brith.
Med. Jour. 1991;302:1302-1305.
36- Kikuchi S, Wada O, Nakajima T, et al. Serum antiHelicobacter pylori antibady and gastric carcinoma among
young adults. Cancer 1995; 75:2789-2793.
37- The Eurogast Study Group. An International association
between Helicobacter pylori infection and gastric cancer.
Lancet 1993; 341:1359-1362.
38- IARC Schitosomes, liver flukes and Helicobacter pylori in
IARC monographs on the evaluation of carcinogenic risks to
humans. Genova 1994; WHO publication No:61.
39- Correa P. A human model of gastric carcinogenesis. Cancer
Res. 1988, 48: 3554-3560.
40- Lee S, Iida M, Yao T, et. al. Risk of gastric cancer in patients
with nonsurgically treated peptic ulcer. Scand J Gastroenterol
1990; 25(12):1223-1226.
41- Kuipers EJ, Perez – Perez GI, Meuwissen SGM, et al.
Helicobacter pylori and atrofic gastritis: İmpertance of the cag
A status. J Natl Cancer Inst 1995; 87: 1777-1780.
42- Blaser MJ, Chyou PH, Nomura A. Age at establishment of
Helicobacter pylori infection and gastric carcinoma, gastric
ulcer and duodenal ulcer risk Cancer Res. 1998; 40: 1627-
1631.
43- Lipkin M. Biomarkers of increased susceptibilitiy to
gastrointestinal cancer: new aplication to studies of cancer
prevention in human subjects. Cancer Res 1998; 40: 1627-31.
44- Smoot DT. How does Helicobacter pylori cause mucosel
damage? Direkt mechanisms. Gastroenterology 1997; 113
(suppl): S31- S34.
45- Jones LN, Shannon PT, Cutz E, Yeger H, Sherman PM.
İncrease in proliferation and Apoptosis of Gastrik Epithelial
Cells Earlıf in the Natural History of Helicobactetr pylori
Infection. Am J Pathol 1997; 151: 6 1695-1703.
46- Moss SF, Calam J, Agarwall B, Wang S, Holt PR. Induction
of gastric epitheilal apoptosis by Helicobacter pylori. Gut
1996; 38: 498- 501.
47- Mannick EE, Bravo LE, Zarama G et al. Inducible nitric oxide
synthase, nitrotyrosine and apoptosis in Helicobacter pylori
gastritis: effect of antibiotics and anitoxidants. Cancer Res
1996; 56: 3238 – 3243.
48- El-Zimaity HMT, Graham DY, Genta MR, Lechago J.
Sustained increase in gastric antral epithelial cell proliferation.
Despite cure of Helicobacter pylori infection. Am J
Gastroenteral 2000; 95(4) 930-935.
49- Chow KW, Bank S, Ahn S, et. al. Helicobacter pylori
infection does not increase gastric antrum mucosel cell
praliferation. Am J Gastroenterol 1995; 90: 64-66.
50- Lynch DA, Axon AT. Helicobacter pylori, gastric cancer and
gastirc epthelial kineticks: a review. Eur J Gastroenterol
Hepatol 1995; 7 (Suppl 1): S17-S23.
Helicobacter pylori
NH4,
sitotoksinler,
Epitelyal hasar
Hiperproliferasyo
n
İnflamasyon
Potansiyel
mutajenik
substanslar
Çevresel ve
kişisel
DNA HASARI
GASTRİK KANSER
−
+Helicobacter Pylori ve Gastrik Karsinogenez
33
51- Collins JS, Hamilton PW, Watt PC, Sloan JM, Love AH.
Superficial gastritis and Compylobacter pylori in dyspeptic
patients. A quantitative study using computer – linked image
analysis J Pathol 1989; 158: 303-310.
52- Armuzzi A, Ioscane E, Pignataro G, et. al. Gastric epithelial
cell kinetics and inflamatory cell infiltration in Helicobacter
pylori antral gastritis: quantitative computer assisted image
analysis (abstract) Gut 1996; 39 (suppl 2) A 106.
53- Wagner S, Beil W, Westermann J,Logan RP, Bock CT,
Trautwein C, Bleck JS, Manns MP. Regulation of gastric
epithelial cell growth by Helicobacter pylori:evidence for a
major role of apoptosis. Gastroenterology 1997;113:1836-
1847.
54- Knipp U, Birkholz S, Kaup W, Opferkuch W. Partial
characterization of a cell proliferation-inhibiting protein
produced by Helicobacter pylori. Infect Immun 1996; 64:
3491-3496.
55- Tsujii M, Kawano S, Tsujii S, et al. Cell kinetics of mucosal
atrophy in rat stomach induced by long-term administration of
ammonia. Gastroenterology 1993;104:796-801.
56- Dockray GJ. Topical review. Gastrin and gastric epithelial
physiology. J Physiol (Lond) 1999 6,15; 518 (Pt 2): 315-24.
57- Blaser MJ. The role of Helicobacter pylori in gastritis and its
progression to peptic ulcer disease. Liment Pharmacol Ther
995;9 (suppl):27-30.
58- Iascone E, Armuzzi A, Covino M, et al. Epithelial cell kinetics
changes in Helicobacter pylori associated gastritis [abstract].
Gut 1996; 39 (suppl 2):A57.
59- Anti M, Armuzzi A, Gasbarrini G. Importance of changes in
epithelial cell turnover during Helicobacter pylori infection in
gastric carcinogenesis. Gut 1998; 43 (suppl 1): S27-S32.
60- Honig A, Witte F, Mirecka J et al. Helicobacter pyloriinduced hyperproliferation: relevance for gastric cancer
development in connection with mutagenic factors. Anticancer
Res 2000; 5-6;20 (3A):1641-8.
61- Siurala M, Sipponen P, Kekki M. Chronic gastritis: dynamic
and clinical aspects. Scand J Gasroenterol 1985; 20(Suppl
109):69-76.
62- Kuipers EJ, Uyterlinde AM, Pena AS et al. Long-term
sequelae of Helicobacter pylori gastritis. Lancet 1995;
345:1525-8.
63- Lynch DA, Mapstone NP, Clarke AMT, et al. Cell
proliferation in Helicobacter pylori associated gastritis and the
effect of eradication therapy. Gut 1995; 36:346-50.
64- Cahill RJ, Xia H, Kilgallen C, et al. Effect of eradication of
Helicobacter pylori infection on gartric epithelial cell
proliferation. Dig Dis Sci 1995; 40:1627-31.
65- Ierardi E, Francavilla A, Balzano T, et al. Effect of
Helicobacter pylori eradication on gastric epithelial
proliferation, relationship with ras oncogene p21 expression.
Ital J Gastroenterol Hepatol 1997; 29:214-19.
66- Sung JJ, Lin SR, Ching JY et al. Atrophy and intestinal
metapilazi one year after cure of Helicobacter pylori
infection: A prospective, randomized study. Gastroenterology
2000 6;119(1):7-4.
67- Asaka M, Takeda H, Sugiyama T, Kato M. What Role Does
Helicobacter pylori in Gastric Cancer? Gastroenterology
1997;113:S56-S60.
68- Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with
Helicobacter pylori strains possessing cagA is associated with
an increased risk of developing adenocarcinoma of the
stomach. Cancer Res 1995; 55:2111-2115.
69- Katagiri M, Takeda H, Kudo M et al. Infection with cagA
Helicobacter pylori strains is not associated with gastric
cancer in Japan. Gastroenterology 1997;112:A589.
70- Ricci V, Ciacci C, Zarrilli R, et al. Effect of Helicobacter
pylori on gastric epithelial cell migration and proliferation in
vitro: role of VacA and CagA. Infect Immun 1996; 64:2829-
33.
71- Akkuş İ. Serbest radikaller ve fizyopatolojik etkileri. 1995.
Mimoza Yayınları.
72- de Groot H. Reactive Oxygen species in tissue injury.
Hepatogastroenterology 1994; 41: 328-332.
73- Adelman R, Saul RL, Ames BN. Oxidative damage to DNA:
relation to species metabolic rate and life span. Proc Natl
Acad Sci USA 1988; 85: 2706 – 2718.
74- Davies GR, Simmonds NJ, Stevens TR et al. Helicobacter
pylori stimulates antral mucosal reactive oxygen metabolite
production in vivo. Gut 1994; 35:179-185.
75- Baik SC, Youn HS, Chung MH et al. Increased oxidative
DNA damage in Helicobacter pylori-infected human gastric
mucosa. Cancer Res. 1996; 56:1279-1282.
76- Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori
cause DNA damage in gastric epithelial cells. Carcinogenesis
2000; Vol.21, No. 6 p:1111-1115.
77- Farinati F, Cardin R, Degan P, Rugge M, Di Mario F,
Bonvicini P, Naccarato R. Oxidative DNA damage
accumulation in gastric carcinogenesis. Gut 1998; 42:351-356.
78- Kneller RW, Guo WD, Hsing AW et al. Risk factors for
stomach cancer in sixty – five Chinese counties. Cancer
Epidemiol Biomarkers Prev. 1992; Jan-Feb; 1 (2): 113-118.
79- Sobala GM, Schorah CJ, Shires S et. al. Effect of eradication
of Helicobacter pylori on gastric juice ascorbic acid
concentrations. Gut 1993; 34 (8): 1038-1041.
80- Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, Mc
Coll KE. Effect of Helicobacter pylori and its eradication on
gastric juice ascorbic acid. Gut 1994; 35 (3): 317 – 322.
81- Drake IM, Davis MJ Mapstone NP et. al. Ascorbic acid may
protect against human gastric cancer by scavenging mucosal
oxygen radicals. Carcinogenesis 1996; 17(3): 559 –562.
82- Zhang HM, Wakisaka N, Macda O, Yamamoto Y. Vitamine C
inhibits the growth of a bacterial risk factor for gastric
carcinoma: Helicobacter pylori Cancer 1997; 15 80
(10):1897- 1903.
83- Ames BN. (1989) Mutagenesis and carcinogenesis:
endogenous and exogenous factors. Environ. Mol. Mutagen.,
14(suppl 16), 249-257.
Thank you for copying data from http://www.arastirmax.com